Loading…
Cord Blood Platelet Lysate: In Vitro Evaluation to Support the Use in Regenerative Medicine
Platelet-rich plasma (PRP) is an inexpensive and safe substitute of recombinant growth factors and . Due to its putative effect on tissue repair, the use of autologous PRP has become largely popular. Recently, a jellified PRP derivative obtained from umbilical cord blood (CB) has been utilized to tr...
Saved in:
Published in: | Mediterranean journal of hematology and infectious diseases 2019-01, Vol.11 (1), p.e2019021-e2019021 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Platelet-rich plasma (PRP) is an inexpensive and safe substitute of recombinant growth factors
and
. Due to its putative effect on tissue repair, the use of autologous PRP has become largely popular. Recently, a jellified PRP derivative obtained from umbilical cord blood (CB) has been utilized
to treat mucosal and cutaneous lesions. Nevertheless, whether PRP derived from CB and adult blood display different potency in promoting cell growth
has been rarely investigated. In this study, we compared cytokine profile and mesenchymal cell growth supporting the ability of platelet lysate obtained from adult and cord blood. Our
results strongly back the utilization of CB platelet lysate
, as an efficacious, safe and inexpensive alternative to promote damaged tissue healing when the autologous PRP is contraindicated. Moreover, the policy of manufacturing CB platelet lysate can limit the current disposal of many collected CB units not suitable for transplant due to their low nucleated cell count. |
---|---|
ISSN: | 2035-3006 2035-3006 |
DOI: | 10.4084/MJHID.2019.021 |